Terms: = Head and neck cancer AND HOXD11, ENSG00000128713, 3237 AND Treatment
9 results:
1. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract] [Full Text] [Related]
2. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract] [Full Text] [Related]
3. A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
Cohen EE; Tortorici M; Kim S; Ingrosso A; Pithavala YK; Bycott P
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1261-70. PubMed ID: 25315258
[TBL] [Abstract] [Full Text] [Related]
4. Clinical character of pediatric head and neck rhabdomysarcomas: a 7-year retrospective study.
Zhang WL; Zhang Y; Huang DS; Guo F; Han T; Hong L; Hu HM; Zhi T
Asian Pac J Cancer Prev; 2013; 14(7):4089-93. PubMed ID: 23991958
[TBL] [Abstract] [Full Text] [Related]
5. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract] [Full Text] [Related]
6. Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma.
Rodini CO; Xavier FC; Paiva KB; De Souza Setúbal Destro MF; Moyses RA; Michaluarte P; Carvalho MB; Fukuyama EE; ; Tajara EH; Okamoto OK; Nunes FD
Int J Oncol; 2012 Apr; 40(4):1180-8. PubMed ID: 22227861
[TBL] [Abstract] [Full Text] [Related]
7. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection.
Haddadin KJ; Soutar DS; Oliver RJ; Webster MH; Robertson AG; MacDonald DG
Head Neck; 1999 Sep; 21(6):517-25. PubMed ID: 10449667
[TBL] [Abstract] [Full Text] [Related]
8. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract] [Full Text] [Related]
9. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract] [Full Text] [Related]